Halliburton heads into its July 20 Q2 earnings print with a stock down 14% over the past month, a cluster of insider sales at higher prices, and an analyst community that remains broadly constructive but has quietly started shading targets lower.
The most telling signal this week comes from the Street. Susquehanna trimmed its target to $42 from $45 on July 8 — the day this note is filed — while maintaining a Positive rating. That move lands against a stock trading at $33.79, implying the analyst still sees roughly 24% upside from current levels. The broader direction of recent analyst activity has been bullish: Barclays upgraded to Overweight in May with a $55 target, Citigroup raised to $52 in June, and JPMorgan and Morgan Stanley both lifted targets to $42 after the Q1 print. The consensus remains Hold, with six analysts formally neutral, but the weight of recent target moves has been upward — making Susquehanna's trim a mild note of caution rather than a reversal of tone. Valuation is cheap on most reads: the forward P/E is running near 12.9x, down roughly 3 points over the past month as the stock has sold off, and EV/EBITDA has compressed to around 7.9x — levels that bulls argue price in significant activity slowdown already.
Options positioning has turned noticeably more call-heavy than usual. The put/call ratio is at 0.72, roughly 1.3 standard deviations below its 20-day average of 0.79, and close to the 52-week low of 0.69. That reads as the options market leaning toward upside into earnings rather than hedging against downside — a contrast to the heavier defensive positioning seen across the sector earlier in the year, when the PCR was running above 0.85. Short positioning backs up the relatively relaxed tone. Short interest is around 4% of the free float — up about 5% over the month but hardly extreme. Borrowing shares is essentially frictionless, with the lending pool overwhelmingly unconstrained and cost to borrow at just 0.29%, down sharply on the week from 0.51% a few days prior. The ORTEX short score of 35.4 sits near the 50th percentile, consistent with a stock that bears are watching but not crowding.
Insider activity tells a less comfortable story. Every transaction in the recent window has been a sale. CFO Eric Carre sold $889K worth of shares at $35.89 in mid-June. CEO Jeffrey Miller disposed of $6.3M at $40 in late March. The CLO sold over $8M in May at $41. Taken together, net insider selling in the 90-day window approached $17M — all executed at prices meaningfully above where the stock trades today. These are plan-driven sales in many cases, but the uniformity of direction and the fact that insiders were unloading near recent highs while the stock has since fallen to $33.79 is worth noting. Institutional holders, by contrast, have been adding: BlackRock increased its position by 4.7M shares to nearly 84M, and State Street added 3.6M shares as of June 30.
The earnings history adds useful context. Last quarter, the stock gained 3.2% the day after the print and extended to a 8.2% gain over the following week. The prior Q1 saw a 6.6% one-day move and an 11.3% five-day move. Both prints delivered positive reactions — suggesting the market has rewarded results recently, even in a difficult macro backdrop for oilfield services. Close peers have been mixed on the week: SLB was essentially flat at +0.09%, BKR fell 3.3%, while NBR and PTEN both dropped over 4%. HAL's modest weekly decline of 0.5% looks resilient by comparison within the group.
The setup on July 20 is therefore less about whether HAL can beat in absolute terms and more about how management frames North American completions activity and international momentum heading into the second half — with the bull case resting on margin resilience and new partnerships, and the bear case centered on US land softening and Middle East headwinds that have already pressured guidance from regional operators.
See the live data behind this article on ORTEX.
Open HAL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
